Market Closed -
Other stock markets
|
After market 03:54:09 am | |||
141.1 USD | +0.06% | 141.6 | +0.32% |
02/05 | Ascendis Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/05 | Earnings Flash (ASND) ASCENDIS PHARMA Reports Q1 Revenue EUR95.9M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.03% | 8.06B | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Ascendis Pharma A/S : Morgan Stanley Adjusts Ascendis Pharma PT to $204 From $197, Maintains Overweight Rating